Signant Health Expands Availability of Its EClinical Solutions by Joining IQVIA One Home for Sites Initiative
Signant Health Expands Availability of Its EClinical Solutions by Joining IQVIA One Home for Sites Initiative
PHILADELPHIA, Sept. 4, 2024 /PRNewswire/ -- Signant Health, the leader in evidence generation for modern clinical trials, announced today it has joined IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, in its One Home for Sites initiative.
費城，2024年9月4日 /PRNewswire/ — 現代臨床試驗證據生成領域的領導者Signant Health今天宣佈，它已與全球領先的生命科學行業高級分析、技術解決方案和臨床研究服務提供商IQVIA一起參與其 「一站式服務」 計劃。
IQVIA One Home for Sites is an industry-wide collaboration designed to simplify site conduct when clinical research staff leverage multiple eClinical technologies from multiple solution providers on a trial. Through single sign-on to a common platform, sites enjoy simplified access to trial technologies from IQVIA and other technology partners that have taken the steps to participate in One Home.
IQVIA One Home for Sites是一項全行業合作，旨在簡化臨床研究人員在試驗中利用來自多個解決方案提供商的多種eClinical技術時的研究中心行爲。通過單點登錄通用平台，網站可以簡化訪問IQVIA和其他已採取措施參與One Home的技術合作夥伴提供的試用技術。
One such technology solution that will appear on the One Home for Sites platform is Signant SmartSignals Unified Platform, itself a fully integrated solution consisting of eCOA, EDC, RTSM, eConsent, and telemedicine.
Signant SmartSignals統一平台將出現在One Home for Sites平台上的其中一種技術解決方案，它本身就是一個由ecoA、EDC、RtSM、eConsent和遠程醫療組成的完全集成的解決方案。
"We are very pleased to have our Unified Platform now available within One Home for Sites," said Sanjiv Waghmare, Signant's chief product officer. "IQVIA's industry-wide, collaborative approach aligns well with our overall product strategy to homogenize access to all our products through a single environment we call Signant SmartSignals ID Portal. We applaud IQVIA's efforts to extend this philosophy by consolidating multiple solution providers into one ecosystem for easy access by sites."
Signant首席產品官桑吉夫·瓦格馬爾表示：「我們很高興我們的統一平台現在可以在One Home for Sites中使用。」「IQVIA的全行業協作方法與我們的總體產品戰略非常吻合，即通過一個我們稱之爲Signant SmartSignals ID門戶的單一環境實現對所有產品的同質訪問。我們讚揚IQVIA努力通過將多個解決方案提供商整合到一個生態系統中以方便站點訪問來擴展這一理念。」
"Signant Health quickly recognized the power of One Home for Sites to capture synergies across the industry and deliver a better experience to sites," said Melissa Easy, VP of Commercialization for IQVIA Technologies Digital Products and Services. "We welcome Signant to One Home and look forward to their continued contribution to building the next-generation clinical trial ecosystem that benefits all stakeholders – especially the patients we serve."
IQVIA Technologies數字產品和服務商業化副總裁梅利莎·埃西表示：「Signant Health很快意識到網站一站式服務在整個行業中發揮協同效應併爲網站提供更好的體驗的力量。」「我們歡迎Signant加入One Home，並期待他們繼續爲建立下一代臨床試驗生態系統做出貢獻，使所有利益相關者受益，尤其是我們服務的患者。」
About Signant Health
關於信安健康
Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at .
Signant Health 是一家證據生成公司。我們專注於利用軟件、深厚的治療和科學知識以及運營專業知識，爲傳統、虛擬和混合試驗模型的臨床研究持續採集、彙總和揭示高質量證據。25年來，超過600家各種規模的贊助商和首席投資官——包括所有排名前20的製藥公司——都信任Signant的遠程和現場ecoA、EDC、eConsent、RTSM、供應鏈管理和數據質量分析解決方案。要了解更多，請訪問。
About IQVIA
關於 IQVIA
IQVIA (NYSE: IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA's portfolio of solutions are powered by IQVIA Connected Intelligence to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide.
IQVIA（紐約證券交易所代碼：IQV）是全球領先的生命科學和醫療保健行業臨床研究服務、商業洞察和醫療保健情報提供商。IQVIA的解決方案組合由IQVIA Connected Intelligence提供支持，以高質量的健康數據、醫療保健級人工智能、高級分析、最新技術和廣泛的領域專業知識爲基礎，提供切實可行的見解和服務。IQVIA在100多個國家擁有約88,000名員工，包括醫療保健、生命科學、數據科學、技術和卓越運營方面的專家，致力於加快創新藥物的開發和商業化，以幫助改善全球患者預後和人口健康。
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA's insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit .
IQVIA 是保護個人患者隱私的全球領導者。該公司使用各種隱私增強技術和保障措施來保護個人隱私，同時大規模生成和分析信息，以幫助醫療保健利益相關者識別疾病模式，並與獲得更好療效所需的精確治療路徑和療法相關聯。IQVIA的見解和執行能力幫助生物技術、醫療器械和製藥公司、醫學研究人員、政府機構、付款人和其他醫療保健利益相關者更深入地了解疾病、人類行爲和科學進步，努力推進他們的治療之路。要了解更多信息，請訪問。
Contact:
Heather Bilinski
[email protected]
+1 610.400.4141
聯繫人：
希瑟·比林斯基
[電子郵件保護]
+1 610.400.4141
SOURCE Signant Health
來源 Signant Heal
譯文內容由第三人軟體翻譯。